sulbactam has been researched along with Afibrinogenemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, C; Lin, C; Tan, M; Wang, D; Wang, S; Wu, Y | 1 |
| Fang, Q; Fang, XL; Hu, J; Lai, YX; Xiao, YH; Zheng, Y | 1 |
2 other study(ies) available for sulbactam and Afibrinogenemia
| Article | Year |
|---|---|
Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study.
Topics: Afibrinogenemia; Anti-Bacterial Agents; Cefoperazone; Fibrinogen; Fibrinolytic Agents; Hemoglobins; Hemorrhage; Humans; Retrospective Studies; Sulbactam; Tigecycline | 2023 |
Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.
Topics: Adult; Afibrinogenemia; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Blood Coagulation Tests; Case-Control Studies; Cefoperazone; Critical Illness; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sulbactam; Tigecycline | 2020 |